OBIO Member: CCAB Innovative Collaboration Accelerating Cancer Treatments

OBIO News
Written By obio

OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB) and OBIO Partner, the National Research Council of Canada (NRC) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).

Read the full Press Release HERE

obio
Previous

OBIO Partner: StarFish Medical Acquires Kangaroo Design
Next

CAAP Company: Eve Medical